Choosing the Most Efficacious and Safe Oral Treatment for Idiopathic Overactive Bladder: A Systematic Review and Network Meta-analysis-Reference-Cited by-同舟云学术

Choosing the Most Efficacious and Safe Oral Treatment for Idiopathic Overactive Bladder: A Systematic Review and Network Meta-analysis

Published:2021-09 Issue: Volume: Page:
ISSN:2405-4569
Container-title:European Urology Focus
language:en
Short-container-title:European Urology Focus

Author:

Mostafaei Hadi^ORCID,Salehi-Pourmehr Hanieh,Jilch Sandra,Carlin Greta Lisa,Mori Keiichiro,Quhal Fahad,Pradere Benjamin,Grossmann Nico C.,Laukhtina Ekaterina,Schuettfort Victor M.,Aydh Abdulmajeed,Sari Motlagh Reza,König Frederik,Roehrborn Claus G.,Katayama Satoshi,Rajwa Pawel,Hajebrahimi Sakineh,Shariat Shahrokh F.

Publisher

Elsevier BV

Subject

Urology

Reference86 articles.

1. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction;Haylen;Int Urogynecol J,2010

2. The association of adiposity and overactive bladder appears to differ by gender: results from the Boston Area Community Health survey;Link;J Urol,2011

3. Sex differences in the physiology and pharmacology of the lower urinary tract;Patra;Curr Urol,2013

4. Do patient characteristics predict responsiveness to treatment of overactive bladder with antimuscarinic agents?;Herschorn;Urology,2014

5. Idiopathic and neurogenic detrusor overactivity: do the different patterns have urodynamic characteristics related to gender or neurological condition?;Valentini;Int Braz J Urol,2013

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. External validation demonstrates machine learning models outperform human experts in prediction of objective and patient-reported overactive bladder treatment outcomes;Urology;2024-09

2. Animal models, treatment options, and biomaterials for female stress urinary incontinence;Frontiers in Bioengineering and Biotechnology;2024-08-29

3. An Evidence-Based Update on Anticholinergic Use for Drug-Induced Movement Disorders;CNS Drugs;2024-03-19

4. Risks of Dementia After Treatment with an Anticholinergic, Beta-3 Agonist, or Combination of Both for an Overactive Bladder: A Korean National Cohort Study;European Urology Focus;2024-03

5. Current optimal pharmacologic therapies for overactive bladder;Expert Opinion on Pharmacotherapy;2023-10-05